Ge Chen1, Aikeremujiang Muheremu2, Liu Yang3, Xianzhe Wu4, Peng He5, Huaquan Fan3, Juncai Liu1, Chang Chen1, Zhong Li1, Fuyou Wang3. 1. Department of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, P.R. China. 2. Department of Orthopedics, Peking University Third Hospital, Beijing, P.R. China. 3. Center for Joint Surgery, Southwest Hospital, Third Military Medical University, Chongqing, P.R. China. 4. Chongqing Institute of Optics and Mechanics, Chongqing, P.R. China. 5. Chongqing ITMDC Technology Co., Ltd., Chongqing, P.R. China.
Abstract
Entities:
Keywords:
Pelvis; case report; chondrosarcoma; implant; three-dimensional printing; titanium
The incidence of malignant tumors is consistently on the rise because of
environmental changes and the aging of the population. In patients with massive
pelvic sarcomas, the bone defect after resection of an osteogenic tumor requires a
large bone transplantation and implant fixation.[1-3] However, complex implant systems
are likely to fall apart in many patients shortly after surgery. Three-dimensional
(3D) printing technology uses a digitized model and specific materials to print out
the structure.[4,5] Since its
creation in the 1980s, 3D printing has been widely applied in various fields
including the military, architecture, and medical fields.[6,7] With the application of
neoadjuvant chemotherapy, limb-salvage surgery has become a common procedure in the
treatment of osseous sarcomas of the extremities. In patients who undergo massive
tissue removal, individualized implants can be extremely helpful because many large
bone defects cannot be easily bridged by standard implants.[8,9] However, although 3D printing
technology has been widely used for preoperative surgical planning, customized
3D-printed implants have rarely been used in clinical practice. We herein describe a
patient treated with 3D-printed implants for reconstruction of the pelvic bone after
removal of a giant chondrosarcoma.
Case presentation
A 29-year-old woman presented to our clinic with a 10-year history of a growing lump
in the left thigh. The patient had experienced no pain associated with the lump, no
pain or analgesia of the lower extremities, and no difficulty in urination or
defecation; however, she reported some difficulty in mobility. Physical examination
revealed normal mobility of the spine and lower extremities. A hard bump with a
diameter of 15 × 15 cm was palpated in the right pelvis. Examination revealed no
redness, swelling, or pain around the lump; no muscular atrophy or weakness; no
dislocation or malformation of the joints; and no varicose veins in the lower
extremities. The length of both legs was 71 cm; no discrepancy was observed in the
length of the two legs. The Harris hip score before surgery was 86 as evaluated
based on the patient’s self-reported pain, functional capacity, malformation of the
lower extremity, and range of motion.The outpatient X-ray showed a large bone and soft tissue tumor eroding the pubic
bone, ischium, and acetabulum. The patient was admitted to the ward, and further
radiological studies were carried out. Computed tomography (CT) and magnetic
resonance imagery showed that the tumor had invaded the inner left thigh (Figure 1). CT angiography
showed that the left femoral artery and deep femoral artery had been shifted by the
tumor. A diagnosis of mucinous chondrosarcoma was suggested by fine needle
biopsy.
Figure 1.
Three-dimensional reconstruction of the patient’s computed tomography
scan.
Three-dimensional reconstruction of the patient’s computed tomography
scan.After ruling out deficiencies of the circulatory, respiratory, urinary, and
gastrointestinal systems, a multidisciplinary discussion was conducted among the
oncologists, orthopedic surgeons, and researchers. Considering the large structural
defect that would be present after removal of the tumor, intraoperative application
of a 3D-printed implant was suggested. No chemotherapy was administered because of
the nature of chondrosarcoma. A surgery was scheduled after the patient provided
written informed consent. The 3D-printed implant was prepared by reconstruction of
the patient’s CT scan (Figure
2). A chordoma was also found in the patient’s right femur. No surgical
intervention was scheduled because the chordoma was not causing pain, analgesia, or
loss of mobility.
Figure 2.
Design and mold of the three-dimensional implant used in the current
case.
Design and mold of the three-dimensional implant used in the current
case.CT scans of the pelvic bone and upper one-third of the femoral bone were obtained by
a CT scanner (Siemens Healthineers, Erlangen, Germany) with 1.0-mm slices. The data
were stored and analyzed by Mimics 17.0 software (Materialise, Leuven, Belgium) in
Digital Imaging and Communications in Medicine® format. After a 3D model of the
pelvic bone had been constructed by Mimics 17.0 software, it was imported into
Siemens NX software (Siemens PLM Software, Plano, TX, USA) to design the guiding
template. When designing the template, the resection margin was extended 1 to 2 cm
beyond the perimeter of the tumor. The design of the guiding template was stored in
stereolithography format and printed by a UP BOX+ 3D printer (Beijing Tiertime
Technology Co., Ltd., Beijing, China) using polylactic acid.Although titanium alloys are widely used in orthopedic surgeries because of their
outstanding biocompatibility and biomechanical characteristics, some reports have
described implant loosening and bone resorption due to the stress shielding effect
after the application of titanium implants.[10] To avoid this effect, we used a porous structure 3D painted implant in which
the diameter of each aperture was 200 µm, the extent of porosity was 38%, and the
density was 2.8 g/m3. Suture anchors for fixation of the muscles and
ligaments were designed on the implant according to the 3D-reconstructed CT
data.
Surgical procedure
After all preoperative preparations were complete, en bloc tumor resection and 3D
implant fixation were performed with the consent of the patient and her family
(Figure 3). The surgery
was carried out with the patient under general anesthesia. The patient was fixed in
the right lateral position. After disinfection of the surgical field, the first
incision was made horizontally on the crest of the ilium along the groin; a second
incision was made longitudinally along the tumor and femoral vessels. The added
length of the incision was 40 cm. After exposing the iliac periosteum, the tumor was
isolated and resected using the 3D-printed guiding template. The left superior
acetabulum, pubic symphysis, and femoral neck were resected and sent out for
pathologic diagnosis. The cartilage on the right pubic symphysis was removed, and
the implant was fixed on the bleeding bone bed with screws. The hip was abducted and
externally rotated to expose the femoral neck, which was then sawed 1 cm superior to
the lesser trochanter. After the reaming was deemed satisfactory, the hip joint was
repositioned with a standard femoral neck and head. Intraoperative C-arm X-ray was
used to confirm the position of the implants. The hip joint was dislocated, the bone
cement was used to fill the 3D-printed acetabulum, and a polyethylene socket (#48;
Johnson & Johnson, New Brunswick, NJ, USA) was fixed in the acetabulum in the
40° abduction and 20° anteversion position. After the bone cement was solid, a
femoral stem prosthesis (#10; Johnson & Johnson) and femoral head prosthesis
(M-SPEC metal Φ28 mm; Johnson & Johnson) were inserted, and the hip joint was
restored. After assuring the mobility of the joint, the surgical field was washed
with sterile physiological saline. The iliotibial tract was repaired; the quadriceps
femoris muscle, iliacus muscle, and biceps femoris muscles were sutured onto the
ischial tuberosity; and the incision was sutured in layers over a drainage tube. The
whole surgery lasted 5 hours, and the intraoperative hemorrhage volume was 2000 mL.
The removed tumor was a solid mass of 12 × 8 × 6 cm with clear margins (Figure 4). When the tumor was
dissected after the surgery, white bone-like tissue with little tissue necrosis was
observed. Pathological studies of the intraoperative specimen confirmed the
preoperative diagnosis of mucinous chondrosarcoma (Figure 5).
Figure 3.
Surgical procedure of tumor resection and three-dimensional implant
fixation.
Figure 4.
Tumor extraction during surgery.
Figure 5.
Pathological studies of the intraoperative specimen confirmed the
preoperative diagnosis of mucinous chondrosarcoma.
Surgical procedure of tumor resection and three-dimensional implant
fixation.Tumor extraction during surgery.Pathological studies of the intraoperative specimen confirmed the
preoperative diagnosis of mucinous chondrosarcoma.After the surgery, cefuroxime and vancomycin were used to prevent surgical site
infection. The patient’s blood hemoglobin concentration was <80 g/L; therefore,
200 and 300 mL of suspended red blood cells were infused 48 and 72 hours
postoperatively, respectively. The drainage tube was removed 7 days after surgery,
and the surgical site healed without infection (Figure 6). The sutures were removed 14 days
after surgery, and physiotherapy was started 1 month after surgery. The patient was
scheduled for outpatient visits every 3 months.
Figure 6.
The surgical site healed without infection.
The surgical site healed without infection.
Results
The patient achieved rapid recovery after the surgery, and no failure or loosening of
the implant occurred after the patient began walking without an external aid (Figure 7). The length of the
left leg and right leg was 72.5 and 71.0 cm, respectively. The Harris hip score was
73 at 1 month postoperatively, 79 at 6 months postoperatively, and 92 at 12 months
postoperatively. No failure or loosening of the implant was evident at 6 months
postoperatively (Figure 8,
Video 1) or 12 months postoperatively (Figure 9, Video 2). The chordoma in the right
femur did not progress during follow-up.
Figure 7.
No failure or loosening of the implant occurred when the patient started
walking after the surgery.
Figure 8.
Video 1: No failure or loosening of the implant had occurred 6 months
postoperatively.
Figure 9.
Video 2: No failure or loosening of the implant had occurred 12 months
postoperatively.
No failure or loosening of the implant occurred when the patient started
walking after the surgery.Video 1: No failure or loosening of the implant had occurred 6 months
postoperatively.Video 2: No failure or loosening of the implant had occurred 12 months
postoperatively.
Discussion
Chondrosarcoma may go unnoticed because of its typical clinical manifestations, such
as lack of pain and minimal effect on patient mobility. Patients in rural areas may
go without treatment of chondrosarcoma for many years. In the current case, the
patient ignored the obvious lump in her left thigh for as long as 10 years. By the
time she sought medical attention, the tumor had eroded the pelvic bone to an extent
that the postoperative bone defect could not be easily bridged by conventional
metallic implants and bone grafts. Biological and prosthetic reconstruction has been
used as the standard for pelvic reconstruction. However, 3D printing technology has
certain advantages over conventional techniques.[11-13] It allows for printing of
precise personalized implants using the patient’s X-ray, CT, and magnetic resonance
imaging data, eliminating the need for a second surgery to harvest autologous bone
grafts to fill the voids that might have been present with conventional implants.
The accurate personalized design of the implants also reduces the need for
allogeneic bone transplants, significantly reducing the duration of
surgery.[14,15] The total cost in our case was 96,380 Yuan ($13,768), which is
similar to patients treated with conventional methods. However, because this
technique is relatively new and not yet widely applied in clinical practice, the
design and manufacturing of the customized implant could be costly.Conventionally, the precision of en bloc resection of osseous sarcomas is dependent
upon the surgeon’s experience. In our case, considering that the iliac tumor was an
Enneking grade Ib chondrosarcoma, the consensus of the orthopedic, oncologic, and
pathologic surgeons was removal of 1 to 2 cm of normal tissue, and the patient
achieved good functional recovery with no recurrence.With the application of 3D-printed intraoperative guidelines, high-precision tumor
removal can be achieved with adequate preoperative planning by most
surgeons.[16,17] Because of the anatomic variations and differences in bone
defects due to tumor removal among different patients, a more personalized implant
with soft tissue docks can be beneficial for functional recovery. 3D printing can
provide precise locations for the attachment of muscles and ligaments on the
implants, increasing the stability of the implant and making it possible for the
patients to achieve better functional recovery after surgery.[18-20] We have herein reported a
typical case of a complex pelvic tumor requiring a prosthetic replacement. 3D
printing is currently a hot technology that conforms to the principle of precision
therapy. It is an appropriate choice in complex orthopedic surgeries. In our case,
despite the removal of a large portion of the pelvic bone and surrounding soft
tissues, the patient achieved satisfactory mobility without implant loosening.
Because 3D printing allows precise treatment, usually without the need for multiple
intraoperative attempts to mold the acetabular cup, the duration of surgery was
controlled within 5 hours, and most of this time was spent on removal of the giant
tumor.There are apparent disadvantages associated with this technique. The designing and
printing process of 3D implants can be time-consuming. The patient in our case had
to wait 1 month for completion of her 3D implant. Additional ethical and technical
regulations may be needed for the application of this technique. However,
considering that its advantages far outweigh its disadvantages and that most
technical problems can be solved with further research, we are confident that
3D-printed implants will be widely applied in future to benefit millions of
patients.
Authors: Nicolas Martelli; Carole Serrano; Hélène van den Brink; Judith Pineau; Patrice Prognon; Isabelle Borget; Salma El Batti Journal: Surgery Date: 2016-01-30 Impact factor: 3.982
Authors: Wen Jie Choy; Ralph J Mobbs; Ben Wilcox; Steven Phan; Kevin Phan; Chester E Sutterlin Journal: World Neurosurg Date: 2017-05-31 Impact factor: 2.104
Authors: Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig Journal: Adv Drug Deliv Rev Date: 2014-08-07 Impact factor: 15.470
Authors: Ahmed Habib; Nicolina Jovanovich; Nallammai Muthiah; Ali Alattar; Nima Alan; Nitin Agarwal; Alp Ozpinar; David Kojo Hamilton Journal: Eur Spine J Date: 2022-05-19 Impact factor: 2.721
Authors: Dung Tran Trung; Sang Nguyen Tran Quang; Hieu Pham Trung; Nam Vu Tu; Nang Vo Sy Quyen; Thanh Tran Duc; Nguyen Tien Dung; Tran Thiet Son; Pham Thi Viet Dung; Nguyen Van Truong Journal: Ann Med Surg (Lond) Date: 2021-09-08
Authors: Marleny M Vega; Geng Li; Mohammad S Shourijeh; Di Ao; Robert C Weinschenk; Carolynn Patten; Josep M Font-Llagunes; Valerae O Lewis; Benjamin J Fregly Journal: Front Bioeng Biotechnol Date: 2022-09-28